Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol
- PMID: 17587572
- PMCID: PMC2001289
- DOI: 10.1016/j.bmcl.2007.06.024
Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol
Abstract
A series of new bisphenol derivatives bearing allylic moieties were synthesized as potential analogs of honokiol and/or magnolol. Certain compounds exhibited specific anti-proliferation activity against SVR cells and moderate anti-HIV-1 activity in primary human lymphocytes. Compound 5h was the most potent compound and its anti-tumor activity was evaluated in vivo.
Similar articles
-
Cytotoxic neolignans: an SAR study.Bioorg Med Chem Lett. 2005 Jan 3;15(1):163-6. doi: 10.1016/j.bmcl.2004.10.011. Bioorg Med Chem Lett. 2005. PMID: 15582432
-
Synthesis, Characterization and Biological Evaluation of Magnolol and Honokiol Derivatives with 1,3,5-Triazine of Metformin Cyclization.Molecules. 2020 Dec 8;25(24):5779. doi: 10.3390/molecules25245779. Molecules. 2020. PMID: 33302335 Free PMC article.
-
Design and synthesis of novel magnolol derivatives as potential antimicrobial and antiproliferative compounds.Eur J Med Chem. 2012 May;51:35-41. doi: 10.1016/j.ejmech.2011.12.039. Epub 2012 Jan 30. Eur J Med Chem. 2012. PMID: 22424614
-
Advances on Semisynthesis, Total Synthesis, and Structure-Activity Relationships of Honokiol and Magnolol Derivatives.Mini Rev Med Chem. 2016;16(5):404-26. doi: 10.2174/1389557516666151120115558. Mini Rev Med Chem. 2016. PMID: 26586125 Review.
-
Honokiol and magnolol: A review of structure-activity relationships of their derivatives.Phytochemistry. 2024 Jul;223:114132. doi: 10.1016/j.phytochem.2024.114132. Epub 2024 May 5. Phytochemistry. 2024. PMID: 38714288 Review.
Cited by
-
Cardiovascular protection of magnolol: cell-type specificity and dose-related effects.J Biomed Sci. 2012 Jul 31;19(1):70. doi: 10.1186/1423-0127-19-70. J Biomed Sci. 2012. PMID: 22849814 Free PMC article.
-
Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.J Cell Mol Med. 2018 Mar;22(3):1894-1908. doi: 10.1111/jcmm.13474. Epub 2018 Jan 24. J Cell Mol Med. 2018. PMID: 29363886 Free PMC article.
-
Synthesis of tetrahydrohonokiol derivates and their evaluation for cytotoxic activity against CCRF-CEM leukemia, U251 glioblastoma and HCT-116 colon cancer cells.Molecules. 2014 Jan 20;19(1):1223-37. doi: 10.3390/molecules19011223. Molecules. 2014. PMID: 24448063 Free PMC article.
-
Bioactive Compounds: Multi-Targeting Silver Bullets for Preventing and Treating Breast Cancer.Cancers (Basel). 2019 Oct 15;11(10):1563. doi: 10.3390/cancers11101563. Cancers (Basel). 2019. PMID: 31618928 Free PMC article. Review.
-
Honokiol, magnolol and its monoacetyl derivative show strong anti-fungal effect on Fusarium isolates of clinical relevance.PLoS One. 2019 Sep 4;14(9):e0221249. doi: 10.1371/journal.pone.0221249. eCollection 2019. PLoS One. 2019. PMID: 31483823 Free PMC article.
References
-
- Maruyama Y, Kuribara H, Morita M, Yuzurihara M, Weintraub ST. J Nat Prod. 1998;61:135–138. and references cited herein. - PubMed
-
- Lo YC, Teng CM, Chen CF, Chen CC, Hong CY. Biochem Pharmacol. 1994;47:549–553. - PubMed
- Nakazawa T, Yasuda T, Ohsawa K. J Pharm Pharmacol. 2003;55:1583–1591. - PubMed
- Teng CM, Chen CC, Ko FN, Lee LG, Huang TF, Chen YP, Hsu HY. Thromb Res. 1988;50:757–765. - PubMed
- Teng CM, Yu SM, Chen CC, Huang YL, Huang TF. Life Sci. 1990;47:1153–1161. - PubMed
-
- Battle TE, Arbiser J, Frank DA. Blood. 2005;106(2):690–697. - PubMed
-
- Bai X, Cerimele F, Ushio-Fukai M, Waqas M, Campbell PM, Govindarajan B, Der CJ, Battle T, Frank DA, Ye K, Murad E, Dubiel W, Soff G, Arbiser JL. J Biol Chem. 2003;278:35501–3557. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources